2025 Emanuele Russo Delphi 共识:快速与先进微生物学方法在重症监护中的作用
该共识由多学科专家组采用德尔菲法,针对16个关键问题达成全部推荐,强调快速微生物检测结果需结合临床背景解读,并与标准培养同时进行以保证病原体检出,快速技术周转时间<24小时具有临床实用性,尤其在严重脓毒症等重症感染中获益。
要点
- 快速微生物检测结果须结合具体临床背景解读。
- 快速检测应同时进行标准培养以检出所有病原体。
- 快速技术周转时间<24小时具有临床实用性。
核心结论
- 该共识为重症患者合理使用快速与先进微生物技术提供指导,但检测设置、解读及不同方法的成本效果分析仍需进一步研究。
研究设计与样本
- 由微生物学家、感染病专家、重症医师、外科医师和肺科医师组成的多学科专家组开展德尔菲共识流程,通过文献回顾和两轮德尔菲调查处理16个优先关键问题,70%的回复显示强烈同意即达成共识。
主要发现
- 全部16条陈述均达成共识。
- 关键发现包括快速微生物检测结果需在特定临床背景下解读。
- 快速检测需同时进行标准培养检查以确保检出所有病原体。
- 快速技术周转时间<24小时具有临床实用性。
- 快速诊断在严重脓毒症和其他严重感染中具有获益。
关键数值与推荐
- 共识阈值:70%的回复显示强烈同意即达成共识。
- 针对疑似感染的重症患者、肺炎和呼吸机相关性肺炎等临床场景提出了快速检测的具体推荐。
- 专家组认为证据不足以支持在各种感染场景中常规使用数字聚合酶链反应(dPCR)。
- 使用先进技术的微生物实验室必须具备临床生物信息学专业知识。
- 需要对临床医生进行基础培训以解读先进微生物技术生成的数据。
临床怎么用
- 在疑似感染的重症患者、肺炎和呼吸机相关性肺炎场景中可参考共识推荐使用快速检测。
- 快速检测结果应结合具体临床背景解读,并同时送检标准培养。
- 不推荐在各种感染场景中常规使用数字聚合酶链反应(dPCR)。
- 使用先进微生物技术的实验室应配备临床生物信息学专业知识。
- 临床医生应接受基础培训以解读先进微生物技术数据。
局限性
- 检测设置、解读及不同方法的成本效果分析标准化仍需进一步研究。
- 专家组认为支持数字聚合酶链反应(dPCR)常规使用的证据不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SCOPE: Interpretation of rapid and advanced microbiological test results remains nonstandardized, with no existing reference guidelines. This study aimed to analyse the existing evidence and provide expert guidance on the use of these techniques in critically ill patients. METHODS: A Delphi consensus process was conducted by a multidisciplinary panel of experts, including microbiologists, infectious disease specialists, intensivists, surgeons, and pulmonologists. Sixteen prioritized key questions were addressed via literature reviews and two Delphi rounds. Consensus was reached when 70% of the responses showed strong agreement. QUESTIONS ADDRESSED BY CONSENSUS AND RECOMMENDATIONS: Consensus was reached for all 16 statements. The key findings include the importance of interpreting rapid microbiological test results within a specific clinical context; the need for concurrent standard culture examinations alongside rapid tests to ensure the detection of all pathogens; the clinical usefulness of turnaround times <24 hours for rapid techniques; and the benefits of rapid diagnostics, particularly in severe sepsis and other severe infections. Specific recommendations were made regarding the use of rapid tests in various clinical settings (critically ill patients with suspected infection, pneumonia, and ventilator-associated pneumonia). The panel found insufficient evidence to support the routine use of digital polymerase chain reaction in various infection scenarios and concluded that clinical bioinformatics expertise is essential in microbiology laboratories that use advanced technologies. The panel also highlighted the need for basic clinician training to interpret data generated using advanced microbiological techniques. This consensus provides guidance for the appropriate use of rapid and advanced microbiological techniques for critically ill patients. However, the standardization of testing settings, interpretations, and cost-effectiveness analyses of different approaches requires further investigation. Robust preanalytical workflows and multidisciplinary clinical bioinformatics expertise are crucial for the effective implementation and interpretation of advanced techniques.
引用
- Sambri V, Agnoletti V, Ambretti S, et al. The role of rapid and advanced microbiological methods in critical care: 2025 Emanuele Russo Delphi consensus. Clin Microbiol Infect. 2025. PMID: 40885382. doi:10.1016/j.cmi.2025.08.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。